Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
CC transcript
Acq. announced
PHARMACOPEIA INC (PCOP) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/23/2008 8-K Quarterly results
11/12/2008 8-K Form 8-K -- Current report
11/07/2008 8-K Form 8-K -- Current report
11/06/2008 8-K Quarterly results
Docs: "Pharmacopeia Announces Third Quarter 2008 Financial Results"
11/04/2008 8-K Form 8-K -- Current report
11/03/2008 8-K Investor presentation
Docs: "Presentation Materials"
10/28/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "Ligand and Pharmacopeia to Present at the Oppenheimer 19 th Annual Healthcare Conference"
10/14/2008 8-K Other Events
10/03/2008 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Other Events, Financial ...
Docs: "Pharmacopeia Receives Notification from NASDAQ"
09/26/2008 8-K Conference call transcript
Docs: "Transcript from Investor Conference Call held on September 24, 2008"
09/25/2008 8-K Entry into a Material Definitive Agreement, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; T...
Docs: "Ligand to Acquire Pharmacopeia for Stock and Contingent Value Rights Acquisition Would Result in Well Capitalized Company with Robust Royalty Assets and Broad Research Pipeline Conference Call Today at 5:30p.m. Eastern",
"Presentation Materials"
09/23/2008 8-K Entry into a Material Definitive Agreement, Departure of Directors or Principal Officers; Election of Directors; Appointment ...
Docs: "Second Amended and Restated Severance Agreement, between Pharmacopeia, Inc. and Rene Belder M.D"
08/05/2008 8-K Investor presentation
Docs: "Pharmacopeia Announces Further Reductions to Workforce",
"Presentation Materials"
08/01/2008 8-K Quarterly results
Docs: "Pharmacopeia Announces Second Quarter 2008 Financial Results Company Updates PS433540 Development Plan and Announces Additional Cost Reductions"
05/30/2008 8-K Cost Associated with Exit or Disposal Activities, Financial Statements and Exhibits
Docs: "Pharmacopeia Advances Strategic Plan to Focus Resources on Development and Later- Stage Discovery Programs"
05/19/2008 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Presentation Materials"
05/16/2008 8-K Regulation FD Disclosure, Other Events, Financial Statements and Exhibits
Docs: "Poster Presentation on Phase 1 Multiple Ascending Dose Study",
"Company Presentation on Phase 2a Study",
"Lead Investigator Presentation on Phase 2a Study",
"PHARMACOPEIA'S FIRST-IN-CLASS INVESTIGATIONAL THERAPY PS433540 ACHIEVES STATISTICALLY SIGNIFICANT REDUCTIONS IN BLOOD PRESSURE IN HYPERTENSIVE PATIENTS"
05/13/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Other Events, Financi...
Docs: "Interim Employment Agreement by and between the Registrant and Joseph A. Mollica"
05/07/2008 8-K Quarterly results
Docs: "Pharmacopeia Announces First Quarter 2008 Financial Results"
05/06/2008 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Certificate of Increase of Shares Designated as Series A Junior Participating Preferred Stock"
04/10/2008 8-K Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers, Financial Statements ...
Docs: "Leslie J. Browne Resigns as President and Chief Executive Officer of Pharmacopeia, Inc. Chairman Assumes Interim Leadership Responsibility"
03/25/2008 8-K Other Events, Financial Statements and Exhibits
Docs: "PHARMACOPEIA TO RECEIVE $5 MILLION PAYMENT FROM GLAXOSMITHKLINE"
02/28/2008 8-K Quarterly results
Docs: "Pharmacopeia Announces Fourth Quarter and Year-End Financial Results for 2007",
"PHARMACOPEIA ANNOUNCES MANAGEMENT TEAM CHANGES"
02/11/2008 8-K Investor presentation
Docs: "Pharmacopeia, Inc. 2008 Incentive Compensation Plan",
"Presentation Materials"
12/18/2007 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Amendment No. 1 to Amended and Restated Bylaws"
12/03/2007 8-K Investor presentation
Docs: "Presentation Materials",
"Pharmacopeia Announces Additional Positive Findings from Phase 1 Multiple Ascending Dose Study of PS433540"
11/14/2007 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Presentation Materials",
"Presentation Materials",
"Presentation Materials"
11/02/2007 8-K Quarterly results
Docs: "PHARMACOPEIA ANNOUNCES THIRD QUARTER 2007 FINANCIAL RESULTS"
10/15/2007 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Docs: "PHARMACOPEIA ACQUIRES SELECTIVE ANDROGEN RECEPTOR MODULATOR PROGRAM FROM BRISTOL-MYERS SQUIBB"
09/28/2007 8-K Other Events, Financial Statements and Exhibits
Docs: "PHASE 2 CLINICAL STUDIES INITIATED FOR A NOVEL THERAPEUTIC CANDIDATE IDENTIFIED THROUGH PHARMACOPEIA COLLABORATION",
"PHARMACOPEIA EARNS MILESTONE PAYMENT FROM SCHERING-PLOUGH ON INITIATION OF PHASE 1 CLINICAL TRIALS OF NOVEL THERAPEUTIC CANDIDATE",
"PHARMACOPEIA CONFIRMS BLOCKADE OF ANGIOTENSIN II RESPONSE WITH FIRST-IN-CLASS PS433540"
09/17/2007 8-K Investor presentation
Docs: "Presentation Materials",
"PHARMACOPEIA ANNOUNCES POSITIVE RESULTS FROM PHASE 1 MULTIPLE ASCENDING DOSE STUDY OF PS433540",
"PHARMACOPEIA INITIATES PHASE 2 HYPERTENSION STUDY WITH PS433540"
09/07/2007 8-K Entry into a Material Definitive Agreement, Departure of Directors or Principal Officers; Election of Directors; Appointment ...
Docs: "Letter Agreement, effective September 6, 2007, between Pharmacopeia, Inc. and Eric J. Liebler",
"Severance Agreement, between Pharmacopeia, Inc. and Eric J. Liebler",
"Letter Agreement, effective August 31, 2007, between Pharmacopeia, Inc. and S. David Kimball, Ph.D",
"Severance Agreement, between Pharmacopeia, Inc. and S. David Kimball, Ph.D"
08/13/2007 8-K Other Events
08/07/2007 8-K Investor presentation
Docs: "Presentation Materials"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy